(98 days)
Not Found
Unknown
The description mentions "image-guided, computer-assisted system" and an "Imaging Subsystem" which could potentially utilize AI/ML for tasks like identifying follicular units. However, the summary does not explicitly state the use of AI, ML, or related terms like deep learning or neural networks. Without further information, it's impossible to definitively confirm or deny the presence of AI/ML.
Yes
The device is marketed for harvesting hair follicles and creating recipient sites for hair transplantation in men with androgenic alopecia, which directly addresses a medical condition and aims to improve a patient's health by alleviating the symptoms of hair loss.
No
The device is used for harvesting and creating recipient sites for hair follicles, not for diagnosing medical conditions.
No
The device description explicitly lists multiple hardware subsystems including a Robotic Arm Subsystem, Imaging Subsystem, Needle Mechanism, Safety Subsystem, Computer, Accessory Kits, and Patient Chair, indicating it is not software-only.
Based on the provided information, the ARTAS™ System is not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for the diagnosis, treatment, or prevention of disease.
- ARTAS System Function: The ARTAS System is a robotic system designed to assist physicians in the physical process of harvesting and creating sites for hair follicles on the scalp. It is a surgical/procedural device, not a device that analyzes biological specimens to provide diagnostic information.
- Intended Use: The intended use clearly states it is for "harvesting hair follicles from the scalp" and "creating recipient sites for subsequent manual implantation." This describes a surgical procedure, not a diagnostic test.
- Device Description: The description details a robotic arm, imaging subsystem, needle mechanism, etc., all components of a surgical assistance system.
- Lack of Specimen Analysis: There is no mention of the ARTAS System collecting, preparing, or analyzing any biological specimens from the patient.
Therefore, the ARTAS System falls under the category of a surgical or procedural device, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The ARTAS™ System from Restoration Robotics is indicated for harvesting hair follicles from the scalp in men diagnosed with androgenic alopecia (male pattern hair loss) who have black or brown straight hair. The ARTAS System from Restoration Robotics is intended to assist physicians in identifying and extracting hair follicular units from the scalp during hair transplantation. The ARTAS System is also indicated for creating recipient sites for subsequent manual implantation of the harvested follicles.
Product codes (comma separated list FDA assigned to the subject device)
ONA
Device Description
The ARTASTM System is an interactive, image-guided, computer-assisted system consisting of seven main subsystems:
-
- Robotic Arm Subsystem
-
- Imaging Subsystem
-
- Needle Mechanism
-
- Safety Subsystem
-
- Computer
-
- Accessory Kits (Disposable and Reusable)
-
- Patient Chair
These main subsystems, with the exception of the Accessory Kits and Patient Chair, are housed on or within a Control Cart.
Mentions image processing
The ARTASTM System is an interactive, image-guided, computer-assisted system.
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Scalp
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Physicians
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
A multi-center, prospective, blinded, clinical study was performed to compare the safety and effectiveness of the ARTAS System to the manual hair follicle harvesting method following a nine month period of post-procedural evaluation. The clinical study enrolled healthy men, between the ages of 30 and 59, who had brown or black straight hair and a clinical diagnosis of androgenetic alopecia (male pattern hair loss). The clinical report generated from this study supported safety and effectiveness of the predicate ARTAS System cleared under 510(k) No. K103428.
An additional safety analysis was performed on the data from this study to demonstrate that the intended use of creating follicular implantation sites do not raise any new issues of safety.
Nonclinical, bench testing included:
- Software verification and validation data.
- Hardware design verification data.
- Implantation site-making performance testing.
The collective results of the nonclinical bench testing demonstrate that the materials chosen, the manufacturing processes, and design of the ARTAS System meet the established specifications necessary for consistent performance during its intended use. In addition, the collective bench testing demonstrates that the ARTAS System does not raise new questions of safety or effectiveness when compared to the predicate devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 882.4560 Stereotaxic instrument.
(a)
Identification. A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.(b)
Classification. Class II (performance standards).
0
Restoration Robotics, Inc.
THE ARTAS™ SYSTEM FROM RESTORATION ROBOTICS
510(k) SUMMARY
510(k) Notification K123548
GENERAL INFORMATION
Applicant:
Restoration Robotics 128 Baytech Drive San Jose, Ca 95134 U.S.A. Phone: 408-883-6760 FAX: 408-883-6889
Contact Person:
Jim Talbot Restoration Robotics 128 Baytech Drive San Jose, Ca 95134 U.S.A. Phone: 408-883-6760 FAX: 408-883-6889
Date Prepared: November 1, 2012
DEVICE INFORMATION
Trade Name: The ARTAS System from Restoration Robotics
Generic/Common Name: Stereotaxic Instrument
Classification: 21CFR§882.4560, Stereotaxic Instrument
Product Code: ONA
$\rho_{i} & \psi$
1
RESTORATION ROBOTICS, INC.
THE ARTAS™ SYSTEM FROM RESTORATION ROBOTICS
510(k) SUMMARY
P224
PREDICATE DEVICE(S)
The proposed ARTASTM System is substantially equivalent to the following predicate devices:
1231-48
- . ARTASTM System, K103428
- Recipient Site Blades (Manual Surgical Instruments, Regulation No. 878.4800, . Class I, exempt)
INTENDED USE
The ARTASTM System from Restoration Robotics is indicated for harvesting hair follicles from the scalp in men diagnosed with androgenic alopecia (male pattern hair loss).who have black or brown straight hair. The ARTAS System from Restoration Robotics is intended to assist physicians in identifying and extracting hair follicular units from the scalp during hair transplantation. The ARTAS System is also indicated for creating recipient sites for subsequent manual implantation of the harvested follicles.
PRODUCT DESCRIPTION
The ARTAS™ System implements the manual Follicular Unit Extraction (FUE) approach to harvesting follicular units and has the potential to solve the technical challenges inherent in the manual FUE technique. The ARTAS™ System is used, under the direction of a physician, to automate the manual FUE technique. The ARTASTM System is positioned over the patient's scalp by the physician and follicular units are identified.
Follicular units are then harvested from the patient's scalp. The follicular units are stored until they are implanted into the patient's scalp by the physician or technician using current manual implantation techniques.
Following harvesting, the ARTAS system is positioned over the patient's scalp by the physician and implantation sites are made in the designated area of the scalp.
The ARTASTM System is an interactive, image-guided, computer-assisted system consisting of seven main subsystems:
-
- Robotic Arm Subsystem
-
- Imaging Subsystem
-
- Needle Mechanism
-
- Safety Subsystem
-
- Computer
-
- Accessory Kits (Disposable and Reusable)
-
- Patient Chair
These main subsystems, with the exception of the Accessory Kits and Patient Chair, are housed on or within a Control Cart.
2
RESTORATION ROBOTICS, INC.
THE ARTAS™ SYSTEM FROM RESTORATION ROBOTIC
510(k) SUMMARY
TECHNOLOGICAL CHARACTERISTICS
The technological characteristics of the ARTAS System from Restoration Robotics are similar to the predicate devices. No changes to the hardware were made to the subject modified ARTAS System, or even to the needle mechanism. Site making is performed simply by replacing one disposable (the harvest needle) with another (the site-making blade).
A new "operation mode" was created within the software for site-making. In this mode you can manually or automatically pick sites within the same tensioner bounds as used by harvesting. The operator can control site density, site depth, and angle at which the blade enters when it makes the site. The software automatically avoids existing hairs exactly as it does during harvest. Other than these few changes, the same software and user interface used by harvesting is used by site-making. Performance Data were provided to support the determination of substantial equivalence.
SUBSTANTIAL EQUIVALENCE
The indications for use for the predicate devices (ARTAS System and the Recipient Site Blades) are substantially equivalent to the proposed indications for use for the proposed ARTAS System. Any differences in the technological characteristics between the devices do not raise any new issues of safety or effectiveness. Thus, the ARTAS System is substantially equivalent to the predicate device.
TESTING IN SUPPORT OF SUBSTANTIAL EQUIVALENCE DETERMINATION
All necessary bench and clinical testing was conducted on the ARTAS System to support a determination of substantial equivalence to the predicate device.
Nonclinical Testing Summary:
The nonclinical, bench testing included:
- Software verification and validation data .
- Hardware design verification data .
- Implantation site-making performance testing .
The collective results of the nonclinical bench testing demonstrate that the materials chosen, the manufacturing processes, and design of the ARTAS System meet the established specifications necessary for consistent performance during its intended use. In addition, the collective bench testing demonstrates that the ARTAS System does not raise new questions of safety or effectiveness when compared to the predicate devices.
Clinical Testing Summary:
A multi-center, prospective, blinded, clinical study was performed to compare the safety and effectiveness of the ARTAS System to the manual hair follicle harvesting method following a nine month period of post-procedural evaluation. The clinical study enrolled healthy men, between the ages of 30 and 59, who had brown or black straight hair and a
3
RESTORATION ROBOTICS, INC.
THE ARTAS™ SYSTEM FROM RESTORATION ROBOTICS
510(k) SUMMARY
clinical diagnosis of androgenetic alopecia (male pattern hair loss). The clinical report generated from this study supported safety and effectiveness of the predicate ARTAS System cleared under 510(k) No. K103428.
An additional safety analysis was performed on the data from this study to demonstrate that the intended use of creating follicular implantation sites do not raise any new issues of safety.
CONCLUSION
The ARTAS System from Restoration Robotics shares its design and mechanism of action as the predicate devices. The results of the nonclinical bench and clinical testing demonstrate that the ARTAS System functions to its specifications and performs as intended. The ARTAS System is substantially equivalent to the predicate devices in terms of technology characteristics, intended use, and performance. No new issues of safety or effectiveness are raised.
SUMMARY
The ARTAS System is substantially equivalent to the predicate device.
4
Image /page/4/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of an eagle with its wings spread, symbolizing the department's mission to protect the health of all Americans.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
February 25, 2013
Restoration Robotics, Incorporated % Mr. Jim Talbot Senior Director, Quality and Regulatory Affairs 128 Baytech Drive San Jose, California 95134
Re: K123548
Trade/Device Name: The ARTAS" System from Restoration Robotics Regulation Number: 21 CFR 882.4560 Regulation Name: Stereotaxic instrument Regulatory Class: Class II Product Code: ONA Dated: January 30, 2013 Received: February 01, 2013
Dear Mr. Talbot:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
5
Page 2 - Mr. Jim Talbot
forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH0ffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
FOR
Peter D. Ryimm -S
Mark N. Melkerson Acting Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
RESTORATION ROBOTICS
THE ARTAS™SYSTEM FROM RESTORATION ROBOTICS 510(k) PREMARKET NOTIFICATION
INDICATIONS FOR USE STATEMENT
510(k) Number (if known): K123548
Device Name: The ARTASTM System from Restoration Robotics
Indications For Use:
The ARTAS™ System from Restoration Robotics is indicated for harvesting hair follicles from the scalp in men diagnosed with androgenic alopecia (male pattern hair loss) who have black or brown straight hair. The ARTAS System from Restoration Robotics is intended to assist physicians in identifying and extracting hair follicular units from the scalp during hair transplantation. The ARTAS System is also indicated for creating recipient sites for subsequent manual implantation of the harvested follicles.
X Prescription Use (Part 21 CFR 801 Subpart D)
AND/OR
(21 CFR 801 Subpart C)
Over-The-Counter Use _
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Neil R Ogden: 2013.02.25 10:41:33 -05'00'
for MXM (Division Sign-Off)
Division of Surgical Devices
510(k) Number